Press release
Austrianova secures Investment from Checkmate Capital
Austrianova logos
SG Austria, with its Austrianova Singapore and Austrianova Thailand subsidiaries, has developed the Cell-in-a-Box® and Bac-in-a-Box® platforms, which use protective cell encapsulation technology to protect, isolate, store, and transfer living human, animal, yeast, and bacteria cells for use in a number of applications. Austrianova Thailand manufactures its Cell-in-a-Box® products at its state-of-the-art facility at Thailand Science Park, in Pathumthani, Thailand (metro Bangkok), which also serves as Austrianova's Cell-in-a-Box® R&D hub. Proceeds from Checkmate Capital's investment will be used to expand this GMP, ISO9001:2015-certified facility.
Walter H. Gunzburg, Chairman of Austrianova, said "It is a great pleasure for us to have the Checkmate Capital team on board. This investment allows Austrianova to expand and extend its existing facility to accommodate additional demand and execute additional projects."
Austrianova CEO, Brian Salmons, added "We value having Checkmate Capital on board, not only for their investment, but also for their strategic advice and support as a company with seasoned expertise. We look forward to working closely with them in the future."
"We are delighted to make this investment in Austrianova, a leading cellular and bacterial encapsulation platform. Austrianova has proven the efficacy and safety of their technology while building the necessary infrastructure, team and facilities to support commercial scaleup with customers. We believe Austrianova fits perfectly within the cross-disciplinary and cross-border platform we have established at Checkmate Capital. We are excited to work with Austrianova's management team to capitalize on their near-term growth opportunities across the biopharmaceutical, agritech and food science industries," stated Tom Paschall, CEO of Checkmate Capital.
Austrianova
The Gemini #03-15, 41 Science Park Rd, Singapore 117610
Financial Information Contact: pierre.faddoul@square-associates.com
Company and Technology Contact: salmons@sgaustria.com
For more information: http://www.austrianova.com
About Austrianova
Austrianova (the SG Austria Group), is a biotech company with a global footprint and operations in Singapore and Thailand. Austrianova utilizes a novel and proprietary technology for the encapsulation of living mammalian (Cell-in-a-Box®) and bacterial (Bac-in-a-Box®) cells. Cell-in-a-Box® protects the encapsulated cells from rejection by the immune system, allows cells to be easily transported, stored and implanted at specific sites in patients. The technology, which has been proven safe and efficacious in clinical trials carried out in Europe, allows companies to develop any kind of cells as a one-for-all living pharmaceutical. Bac-in-a-Box® is a similar protective device adapted for encapsulation of probiotic bacteria where it has human food and animal feed applications as well as rebalancing the microbiome due to its ability to extend storage under lyophilized conditions and to protect encapsulated bacteria against destruction by stomach acid. Austrianova now also offers GMP4Cells that includes competitively priced Master Cell Bank and Working Cell Bank production as well as "Fill and Finish" services for cell therapy products (such as stem cell therapies, biologics produced from cells e.g., vaccines, antibodies, enzymes, recombinant proteins, exosomes, etc.).
About Checkmate Capital
Checkmate Capital is an investment and strategic advisory group managing family office assets with a global commercial and industry-specific network. Checkmate Capital's primary areas of investment are biotechnology, life sciences, medical technology, agriculture technology, energy technology, and other diversified technologies. Our team provides seasoned expertise in our focused industries, leveraging an international group of strategic partners, business talent, and resources. For more information, visit www.checkmatecapital.net.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Austrianova secures Investment from Checkmate Capital here
News-ID: 2956041 • Views: …
More Releases from Austrianova
Austrianova reports successful metronomic treatment using Cell-in-a-Box® in an …
SINGAPORE, December 19, 2023 - Austrianova, a member of the SGAustria group of companies, and a leading provider of cell encapsulated products as well as other biological products and services, today announced a newly published study demonstrating that one administration of Cell-in-a-Box® encapsulated cells followed by multiple rounds (metronomic) of low dose ifosfamide controls tumor growth in a mouse model of pancreatic cancer.*
Chemotherapeutics such as ifosfamide and cyclophosphamide are normally…
Austrianova announces German subsidiary and new location in Singapore
SINGAPORE, November 1st, 2023 - SG Austria ("Austrianova"), a leading provider of cell biological products and services, today announced that it has established a German subsidiary company based in Munich and moved to a new location in Singapore.
The German subsidiary, Austrianova Germany, at "Am Klopferspitz" in Martinsried, the world renowned German biotech centre, will function as Austrianova's European base, expanding the company's activities and reach.
This year has been a…
Austrianova and ProAgni sign a licensing and manufacturing agreement for novel, …
Austrianova and ProAgni announced today the signing of a licensing and manufacturing agreement that foresees an intensification of joint activities between the two companies in the area of development and commercialization of shelf stable probiotic additives for cattle feed as well as for other farm animals.
Austrianova, a Singaporean biotech company, has developed its patented Bac-in-a-Box® technology specifically to efficiently protect bacteria from stomach acid as well as to allow…
Austrianova and San Raffaele University & Research Hospital announce the initiat …
The group of Dr. Matteo Bellone, group leader Cellular immunology Unit at San Raffaele University & Research Hospital, has shown that Prevotella melaninogenica, a commensal bacterium of the human gastrointestinal microbiota, can protect against the progression of relatively benign asymptomatic multiple myeloma to the aggressive form of the disease. Delivery of Prevotella melaninogenica in preclinical animal models prevents this progression but large doses of the bacteria are needed since they…
More Releases for Austria
I am from Austria! AGROsolution enriches team with new consultant for Austria
Wolfgang Bandion will advise farmers and agricultural dealers in Upper and Lower Austria in the future!
Born in Lower Austria, he has many years of experience as a specialist consultant for arable farming, grassland, viticulture and specialty crops, as well as managing his own farm. "What more could an employer want in terms of agricultural expertise?" say Managing Directors Stefan Stassen and Peter Huemer, who were immediately impressed by Mr. Bandion's…
Austria Agriculture Market | Austria Agriculture Industry | Austria Agriculture …
The share of Austria agriculture within the Austrian economy declined steady afterward World War II, agriculture continues to represent a very important part of the economy attributable to its social and political significance. The Chamber of Agriculture rests on an equal level with the chambers of commerce and labour, though its members manufactures solely a fraction of the GDP that industrial and sale able labours produce. Though little, the agricultural sector is…
Telecoms, Mobile and Broadband 2018-2023 Austria Market Survey Industry Key Play …
WiseGuyReports.com "Austria - Telecoms, Mobile and Broadband - Statistics and Analyses" report has been added to its Research Database.
Scope of the Report:
Austria's telcos looking forward to major spectrum auctions for 5G. Austria's telecom market is dominated by the incumbent Telekom Austria and the cableco UPC Austria, though there has been greater competitive pressure in the fixed-line broadband and mobile sectors in recent years. In common with operators elsewhere in Europe,…
Austria Telecoms, Mobile and Broadband Market Professional Survey with Industry …
WiseGuyReports.com “Austria - Telecoms, Mobile and Broadband - Statistics and Analyses” report has been added to its Research Database.
Scope of the Report:
Austria’s telcos looking forward to major spectrum auctions for 5G. Austria’s telecom market is dominated by the incumbent Telekom Austria and the cableco UPC Austria, though there has been greater competitive pressure in the fixed-line broadband and mobile sectors in recent years. In common with operators elsewhere in Europe,…
Agrochemicals Market in Austria
ReportsWorldwide has announced the addition of a new report title Austria: Agrochemicals: Market Intelligence (2016-2021) to its growing collection of premium market research reports.
The report “Austria: Agrochemicals: Market Intelligence (2016-2021)” provides market intelligence on the different market segments, based on type, active ingredient, formulation, crop, and pest. Market size and forecast (2016-2021) has been provided in terms of both, value (000 USD) and volume (000 KG) in the report. A…
Nazi psychology in Austria
The history of academic psychology after the "Anschluss", the annexation of Austria by Germany in 1938, and its role as a discipline used in National Socialist policies is being examined systematically for the first time in a research project supported by the Austrian Science Fund FWF.
"It is a sad fact”, says psychologist Gerhard Benetka from the Sigmund Freud University Vienna "that applied psychology flourished during the National Socialist era…
